Utpal Koppikar - 16 Mar 2022 Form 3 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role: Director
Signature: /s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol: CCCC
Transactions as of: 16 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 17 Mar 2022, 16:19:37 UTC
Previous filing: 03 Mar 2022
Next filing: 19 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney